Licit and Ilicit Uses of Medicines

Detalhes bibliográficos
Autor(a) principal: Dinis-Oliveira, Ricardo Jorge
Data de Publicação: 2014
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215
Resumo: Drugs of abuse are a heterogeneous group of xenobiotics or endobiotics that alter synaptic organization in the central nervous system in a transient or permanent basis, often leading to a compulsively use. What unites its members is that they confer pleasure (hedonism) to the abusers, namely by their action in the mesolimbic dopamine system. To exert its effects, different drugs of abuse will act on receptors and neurotransmitter transporters, modeling neurotransmitter release into the synaptic cleft. Besides acting on presynapticneurons also function in neurotransmitter receptors and ion channels in postsynaptic neurons, thereby modifying the signaling pathways. In this work, the pharmacodynamic and the potential of some psychoactive substances that are typically subjected to abuse in Portugal, is reviewed. With this approach it was also possible a discussion of drugs of abuse that exhibit very different toxicological effects such as stimulants, depressants and hallucinogens. Particularly, the potential to induce dependence and addition, as well as to undergo illicit and licit uses, of central nervous system depressants, stimulants, anticholinergic antiparkinson drugs, opioids, cannabinoids and hallucinogens, is discussed.Keywords: Antiparkinson Agents; Central Nervous System Depressants; Cholinergic Antagonists; Analgesics, Opioid; Hallucinogens; Central Nervous System Stimulants.
id RCAP_e34c657a1480caccdc3377c06fe5981e
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/5215
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Licit and Ilicit Uses of MedicinesUsos Lícito e Ilícito dos FármacosDrugs of abuse are a heterogeneous group of xenobiotics or endobiotics that alter synaptic organization in the central nervous system in a transient or permanent basis, often leading to a compulsively use. What unites its members is that they confer pleasure (hedonism) to the abusers, namely by their action in the mesolimbic dopamine system. To exert its effects, different drugs of abuse will act on receptors and neurotransmitter transporters, modeling neurotransmitter release into the synaptic cleft. Besides acting on presynapticneurons also function in neurotransmitter receptors and ion channels in postsynaptic neurons, thereby modifying the signaling pathways. In this work, the pharmacodynamic and the potential of some psychoactive substances that are typically subjected to abuse in Portugal, is reviewed. With this approach it was also possible a discussion of drugs of abuse that exhibit very different toxicological effects such as stimulants, depressants and hallucinogens. Particularly, the potential to induce dependence and addition, as well as to undergo illicit and licit uses, of central nervous system depressants, stimulants, anticholinergic antiparkinson drugs, opioids, cannabinoids and hallucinogens, is discussed.Keywords: Antiparkinson Agents; Central Nervous System Depressants; Cholinergic Antagonists; Analgesics, Opioid; Hallucinogens; Central Nervous System Stimulants.As drogas de abuso são um grupo heterogéneo de xenobióticos ou endobióticos que alteram a organização sináptica no sistemanervoso central, de modo transitório ou permanente, conduzindo frequentemente ao consumo da droga de forma compulsiva. O que une os seus membros é o facto de conferirem prazer (hedonismo) a quem consome, nomeadamente por influência no sistema mesolímbico da dopamina. Para exercerem os seus efeitos, as diferentes drogas de abuso vão atuar sobre recetores e transportadores de neurotransmissores, modelando a libertação destes para a fenda sináptica. Além de atuar em neurónios pré-sinápticos, também atuam nos recetores de neurotransmissores e canais iónicos nos neurónios pós-sinápticos, ocorrendo desta forma, uma modificação das vias de sinalização. Nesta revisão é discutido a farmacodinâmica de algumas substâncias psicoativas que são alvo de consumoabusivo em Portugal. Com esta abordagem é também possível uma discussão das drogas de abuso que exibem efeitos toxicológicos tão diversos como estimulantes, depressores e alucinogénios. Nomeadamente é discutido o potencial dos (i.e. depressores do sistema nervoso central, estimulantes, antiparkinsónicos anticolinérgicos, opioides, alucinogénios e dos canabinoides) para desenvolverem adição e dependência, bem como serem alvo de utilizações lícitas e ilícitas.Palavras-chave: Antiparkinsonianos; Depressores do Sistema Nervoso Central; Opioides; Antagonistas Colinérgicos; AnalgésicosOpioides; Alucinogénios; Estimulantes do Sistema Nervoso Central.Ordem dos Médicos2014-12-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215oai:ojs.www.actamedicaportuguesa.com:article/5215Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 755-766Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 755-7661646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215/4146https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215/7464Dinis-Oliveira, Ricardo Jorgeinfo:eu-repo/semantics/openAccess2022-12-20T11:04:15Zoai:ojs.www.actamedicaportuguesa.com:article/5215Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:03.020461Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Licit and Ilicit Uses of Medicines
Usos Lícito e Ilícito dos Fármacos
title Licit and Ilicit Uses of Medicines
spellingShingle Licit and Ilicit Uses of Medicines
Dinis-Oliveira, Ricardo Jorge
title_short Licit and Ilicit Uses of Medicines
title_full Licit and Ilicit Uses of Medicines
title_fullStr Licit and Ilicit Uses of Medicines
title_full_unstemmed Licit and Ilicit Uses of Medicines
title_sort Licit and Ilicit Uses of Medicines
author Dinis-Oliveira, Ricardo Jorge
author_facet Dinis-Oliveira, Ricardo Jorge
author_role author
dc.contributor.author.fl_str_mv Dinis-Oliveira, Ricardo Jorge
description Drugs of abuse are a heterogeneous group of xenobiotics or endobiotics that alter synaptic organization in the central nervous system in a transient or permanent basis, often leading to a compulsively use. What unites its members is that they confer pleasure (hedonism) to the abusers, namely by their action in the mesolimbic dopamine system. To exert its effects, different drugs of abuse will act on receptors and neurotransmitter transporters, modeling neurotransmitter release into the synaptic cleft. Besides acting on presynapticneurons also function in neurotransmitter receptors and ion channels in postsynaptic neurons, thereby modifying the signaling pathways. In this work, the pharmacodynamic and the potential of some psychoactive substances that are typically subjected to abuse in Portugal, is reviewed. With this approach it was also possible a discussion of drugs of abuse that exhibit very different toxicological effects such as stimulants, depressants and hallucinogens. Particularly, the potential to induce dependence and addition, as well as to undergo illicit and licit uses, of central nervous system depressants, stimulants, anticholinergic antiparkinson drugs, opioids, cannabinoids and hallucinogens, is discussed.Keywords: Antiparkinson Agents; Central Nervous System Depressants; Cholinergic Antagonists; Analgesics, Opioid; Hallucinogens; Central Nervous System Stimulants.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215
oai:ojs.www.actamedicaportuguesa.com:article/5215
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/5215
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215/4146
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5215/7464
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 755-766
Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 755-766
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130641488412672